Pulmonary Embolism

Clinical Trial Finder

Many patients with pulmonary embolism are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Investigation of Intravenous Tranexamic Acid With Anatomic and Reverse Total Shoulder Arthroplasty

Conditions:   Blood Loss;   Anatomic Total Shoulder Arthroplasty;   Reverse Total Shoulder Arthroplasty;   Transfusion;   Tranexamic Acid
Interventions:   Drug: Tranexamic Acid;   Drug: Placebo
Sponsor:   Rush University Medical Center
Recruiting - verified October 2015

Bleeding, Cardio- and Cerebrovascular Complications in Head and Neck Surgery

Condition:   Head and Neck Cancer
Sponsors:   University of Turku;   Turku University Hospital
Completed - verified September 2015

Rivaroxaban Utilization for Treatment and Prevention of Thromboembolism in Cancer Patients: Experience at a Comprehensive Cancer Center

Conditions:   Cancer;   Deep-vein Thrombosis of the Lower and Upper Extremities;   Pulmonary Embolism;   Non-valvular Atrial Fibrillation
Intervention:   Other: Retrospective Chart Review
Sponsors:   M.D. Anderson Cancer Center;   Janssen Scientific Affairs, LLC
Recruiting - verified September 2015

Predicting the Safety and Effectiveness of Inferior Vena Cava Filters

Condition:   Pulmonary Embolism
Intervention:   Device: IVC Filter
Sponsors:   New England Research Institutes;   IVC Filter Study Group Foundation (IDE Sponsor);   ALN Implants Chirurgicaux;   B. Braun Interventional Systems, Inc;   Bard Peripheral Vascular, Inc;   Cook;   Cordis Corporation;   Volcano Corporation;   Rex Medical
Not yet recruiting - verified October 2015

Safety and Efficacy Study of Apixaban to Prevent Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With PEG Asparaginase

Conditions:   Lymphoma;   Acute Lymphoblastic Leukemia
Interventions:   Drug: Apixaban;   Other: No systemic anticoagulant prophylaxis
Sponsor:   Bristol-Myers Squibb
Recruiting - verified October 2015

Diuretic Versus Placebo in Pulmonary Embolism

Condition:   Pulmonary Embolism With Right Ventricle Enlargement
Interventions:   Drug: Diuretics : Furosemide;   Drug: Placebo
Sponsor:   Assistance Publique - Hôpitaux de Paris
Recruiting - verified October 2015

Prevention of Silent Cerebral Thromboembolism by Oral Anticoagulation With Dabigatran After Pulmonary Vein Isolation for Atrial Fibrillation

Conditions:   Atrial Fibrillation;   Cardioembolic Events;   Oral Anticoagulation
Intervention:   Drug: Dabigatran
Sponsors:   Georg Nickenig;   Boehringer Ingelheim
Recruiting - verified October 2015

Magnetic Resonance Imaging Combined With Venous Ultrasonography of the Legs for Pulmonary Embolism

Condition:   Pulmonary Embolism
Intervention:   Procedure: MRI combined with venous ultrasonography of the legs
Sponsor:   Assistance Publique - Hôpitaux de Paris
Recruiting - verified October 2015

HIP Fracture Accelerated Surgical TreaTment And Care tracK (HIP ATTACK) Trial

Condition:   Hip Fractures
Intervention:   Other: Accelerated medical clearance and surgery
Sponsors:   Population Health Research Institute;   McMaster University
Recruiting - verified October 2015

Hip Fracture Impact on Vascular Events In Noncardiac Surgery patIents: a cOhort evaluatioN (Hip VISION): Pilot Study

Condition:   Hip Fractures
Sponsor:   Population Health Research Institute
Completed - verified October 2015

The SENTRY Clinical Study

Conditions:   Pulmonary Embolism;   Deep Vein Thrombosis
Intervention:   Device: SENTRY IVC Filter
Sponsor:   Novate Medical
Recruiting - verified October 2015

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (UK)

Condition:   Pulmonary Embolism
Interventions:   Drug: Rivaroxaban (Xarelto, Bay59-7939);   Drug: Warfarin
Sponsor:   Bayer
Recruiting - verified October 2015

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Netherlands)

Conditions:   Venous Thrombosis;   Pulmonary Embolism;   Atrial Fibrillation;   Acute Coronary Syndrome
Interventions:   Drug: Rivaroxoban (Xarelto, Bay59-7939);   Drug: Standard of care
Sponsor:   Bayer
Recruiting - verified September 2015

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Germany)

Conditions:   Venous Thrombosis;   Pulmonary Embolism;   Atrial Fibrillation;   Acute Coronary Syndrome
Interventions:   Drug: Rivaroxaban (Xarelto, Bay59-7939);   Drug: Standard of care
Sponsor:   Bayer
Recruiting - verified September 2015

Multi-center Study to Evaluate the Safety of Apixaban (BMS-562247) in Indian Subjects Undergoing Elective Total Knee Replacement or Total Hip Replacement Surgery

Condition:   Anticoagulation
Intervention:   Drug: Apixaban
Sponsors:   Bristol-Myers Squibb;   Pfizer
Recruiting - verified July 2015

Pilot Study: Cardiovascular Events in High Risk Orthopedic Surgical Patients

Conditions:   Coronary Artery Disease;   Cerebral Vascular Disease;   Peripheral Artery Disease;   Renal Insufficiency;   Diabetes;   COPD;   Hypertension;   Active Smoker;   Cancer;   CHF;   Prior DVT/PE
Sponsor:   New York University School of Medicine
Withdrawn - verified October 2015

"Spot Sign" Selection of Intracerebral Hemorrhage to Guide Hemostatic Therapy

Condition:   Stroke
Interventions:   Biological: rfVIIa;   Other: Standard saline solution
Sponsors:   Dr. David Gladstone;   Canadian Institutes of Health Research  (CIHR)
Recruiting - verified October 2015

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Conditions:   Deep Vein Thrombosis;   Venous Thrombosis;   Postphlebitic Syndrome;   Venous Thromboembolism;   Post Thrombotic Syndrome
Intervention:   Drug: Recombinant tissue plasminogen activator (rt-PA)
Sponsors:   Washington University School of Medicine;   McMaster University;   Ontario Clinical Oncology Group (OCOG);   National Heart, Lung, and Blood Institute (NHLBI);   BSN Medical Inc;   Genentech, Inc.;   Medtronic - MITG;   Boston Scientific Corporation;   Mid America Heart Institute;   Society of Interventional Radiology Foundation;   Massachusetts General Hospital
Active, not recruiting - verified October 2015

Get CardioSmart

You're Invited